<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: August 22, 2000
COLORADO MEDTECH, INC.
----------------------
(Exact name of registrant as specified in its charter)
Colorado 000-12471 84-0731006
------------------ ---------------- --------------------
(State or other jurisdiction (Commission File I.R.S. Employer
of incorporation) Number) Identification No.)
6175 Longbow Drive
Boulder, Colorado 80301
-----------------------
(Address, including zip code, of principal executive offices)
(303) 530-2660
--------------
(Registrant's telephone number,
including area code)
<PAGE>
Item 5. Other Events.
Colorado MEDtech, Inc. issued a press release regarding financial results
for its fourth quarter and fiscal year ended June 30, 2000, management changes
and stock repurchase program. The text of the press release is attached hereto
as Exhibit 99.1.
Item 7. Financial Statement and Exhibits.
(c) Exhibits.
No. Description
--- -----------
99.1 Press release dated August 22, 2000
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATED, this 22nd day of August, 2000.
COLORADO MEDTECH, INC.
By:/s/Stephen K. Onody
-------------------
Stephen K. Onody
Chief Executive Officer
-3-
